Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cope TE"" wg kryterium: Autor


Tytuł :
How does age affect the success of total replacement of the hip joint?
Autorzy :
Cope TE
Pokaż więcej
Źródło :
Reviews in Clinical Gerontology; Aug2008, Vol. 18 Issue 3, p211-218, 8p
Czasopismo naukowe
Tytuł :
In vivo PET imaging of neuroinflammation in familial frontotemporal dementia.
Autorzy :
Malpetti M; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK.
Rittman T; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK.
Jones PS; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK.
Cope TE; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK.
Passamonti L; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK.; Istituto di Bioimmagini e Fisiologia Molecolare Consiglio Nazionale delle Ricerche, Milan, Italy.
Bevan-Jones WR; Department of Psychiatry, University of Cambridge, Cambridge, Cambridgeshire, UK.
Patterson K; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK.
Fryer TD; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, Cambridgeshire, UK.
Hong YT; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, Cambridgeshire, UK.
Aigbirhio FI; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, Cambridgeshire, UK.
O'Brien JT; Department of Psychiatry, University of Cambridge, Cambridge, Cambridgeshire, UK.
Rowe JB; Department of Clinical Neurosciences, and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, Cambridgeshire, UK .; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, Cambridgeshire, UK.
Pokaż więcej
Źródło :
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2020 Oct 29. Date of Electronic Publication: 2020 Oct 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
C9orf72 , AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts.
Autorzy :
Costa B; University College London, Institute of Neurology, London, UK.
Manzoni C; School of Pharmacy, University College London, London, UK .; School of Pharmacy, University of Reading, Whiteknights, Reading, UK.
Bernal-Quiros M; Neurogenetics Laboratory, National Hospital for Neurology and Neurosurgery, London, UK.
Kia DA; University College London, Institute of Neurology, London, UK.
Aguilar M; Aptima Clinic, Terrassa, Barcelona, Spain.
Alvarez I; Memory Disorders Unit, Department of Neurology, University Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain.; Fundació per la Recerca Biomèdica i Social Mútua Terrassa, Terrassa, Barcelona, Spain.
Alvarez V; Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Asturias, Spain.
Andreassen O; NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Anfossi M; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Bagnoli S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Benussi L; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Bernardi L; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Binetti G; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Blackburn D; Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, Sheffield, UK.
Boada M; Research Center and Memory Clinic. Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Borroni B; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Bowns L; Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.; MRC Cognition and Brain Sciences Unit, Cambridge University, Cambridge, UK.
Bråthen G; Department of Neurology, University Hospital of Trondheim, Trondheim, Norway.; Department of Neuromedicine and Movement science, Norwegian University of Science and Technology, Trondheim, Norway.
Bruni AC; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Chiang HH; Karolinska Institutet, Dept NVS, Division of Neurogeriatrics, Bioclinicum Solna, Sweden.; Karolinska University Hospital, Unit for Hereditary Dementias, Theme Aging, Solna, Sweden.
Clarimon J; Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Colville S; Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK.
Conidi ME; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Cope TE; Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.; MRC Cognition and Brain Sciences Unit, Cambridge University, Cambridge, UK.
Cruchaga C; NeuroGenomics and Informatics, Washington University, Department of Psychiatry, St. Louis, MO, USA.
Cupidi C; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Di Battista ME; Cognitive Impairment Center, Local Health Authority n.2 Marca Trevigiana, Treviso, Italy.
Diehl-Schmid J; Technical University of Munich, School of Medicine, Department of Psychiatry and Psychotherapy, Munich, Germany.
Diez-Fairen M; Memory Disorders Unit, Department of Neurology, University Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain.; Fundació per la Recerca Biomèdica i Social Mútua Terrassa, Terrassa, Barcelona, Spain.
Dols-Icardo O; Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Durante E; Immunohematology and Transfusional Medicine Service, Local Health Authority n.2 Marca Trevigiana, Treviso, Italy.
Flisar D; Department of Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia.; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Frangipane F; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Galimberti D; University of Milan, Dino Ferrari Center, Milan, Italy.; Fondazione IRCCS Ca' Granda, Ospedale Policlinico, Milan, Italy.
Gallo M; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Gallucci M; Cognitive Impairment Center, Local Health Authority n.2 Marca Trevigiana, Treviso, Italy.
Ghidoni R; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Graff C; Karolinska Institutet, Dept NVS, Division of Neurogeriatrics, Bioclinicum Solna, Sweden.; Karolinska University Hospital, Unit for Hereditary Dementias, Theme Aging, Solna, Sweden.
Grafman JH; Cognitive Neuroscience Lab, Think and Speak Lab, Shirley Ryan AbilityLab, Chicago, IL, USA.
Grossman M; Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.; Penn Center for Frontotemporal Degeneration, Philadelphia, PA, USA.
Hardy J; University College London, Institute of Neurology, London, UK.; UCL Dementia Research Institute Wing 1.2 Cruciform Building, London, UK; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, 1 Wakefield Street, London WC1N 1PJ, UK; UCL Movement Disorders Centre, University College London, London, UK; Institute for Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China.
Hernández I; Research Center and Memory Clinic. Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Holloway GJ; Royal Edinburgh Hospital, Edinburgh, UK.; Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK.
Huey ED; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.
Illán-Gala I; Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Karydas A; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Khoshnood B; Karolinska Institutet, Dept NVS, Division of Neurogeriatrics, Bioclinicum Solna, Sweden.; Karolinska University Hospital, Unit for Hereditary Dementias, Theme Aging, Solna, Sweden.
Kramberger MG; Department of Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia.; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Kristiansen M; UCL Genomics, UCL Great Ormond Street Institute of Child Health, London, UK.
Lewis PA; University College London, Institute of Neurology, London, UK.; School of Pharmacy, University of Reading, Whiteknights, Reading, UK.; The Royal Veterinary College, Department of Comparative Biomedical Sciences, London, UK.
Lleó A; Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Madhan GK; UCL Genomics, UCL Great Ormond Street Institute of Child Health, London, UK.
Maletta R; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Maver A; Clinical Institute of Medical Genetics, University Medical Center Ljubljana, Ljubljana, Slovenia.
Menendez-Gonzalez M; Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.; Universidad de Oviedo, Oviedo, Asturias, Spain.
Milan G; Geriatric Center Frullone ASL Napoli 1 Centro, Napoli, Italy.; NeurOMICS laboratory, Institute of Biochemistry and Cell Biology (IBBC), CNR Napoli, Napoli, Italy.
Miller B; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Mol MO; Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands.
Momeni P; Rona Holdings, Silicon Valley, CA, USA.
Moreno-Grau S; Research Center and Memory Clinic. Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Morris CM; Newcastle Brain Tissue Resource, Institute of Neuroscience, Newcastle University, Edwardson Building, Campus for Ageing and Vitality, Newcastle upon Tyne, UK.
Nacmias B; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Nilsson C; Department of Neurology, Skåne University Hospital, Malmö, Sweden.; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Novelli V; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Istituto di Medicina Genomica, Università Cattolica del sacro Cuore, Rome, Italy.
Öijerstedt L; Karolinska Institutet, Dept NVS, Division of Neurogeriatrics, Bioclinicum Solna, Sweden.; Karolinska University Hospital, Unit for Hereditary Dementias, Theme Aging, Solna, Sweden.
Padovani A; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Pal S; Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK.; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Panchbhaya Y; UCL Genomics, UCL Great Ormond Street Institute of Child Health, London, UK.
Pastor P; Memory Disorders Unit, Department of Neurology, University Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain.; Fundació per la Recerca Biomèdica i Social Mútua Terrassa, Terrassa, Barcelona, Spain.
Peterlin B; Clinical Institute of Medical Genetics, University Medical Center Ljubljana, Ljubljana, Slovenia.
Piaceri I; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Pickering-Brown S; Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, UK.
Pijnenburg YA; Amsterdam University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Amsterdam, the Netherlands.
Puca AA; Cardiovascular Research Unit, IRCCS Multimedica, Milan, Italy.; Department of Medicine and Surgery, University of Salerno, Baronissi (SA), Italy.
Rainero I; Neurology I, Department of Neuroscience, University of Torino, Torino, Italy.
Rendina A; NeurOMICS laboratory, Institute of Biochemistry and Cell Biology (IBBC), CNR Napoli, Napoli, Italy.
Richardson AM; Manchester Centre for Clinical Neurosciences, Salford Royal NHS Trust, Manchester, UK.; Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, UK.
Rogaeva E; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Rogelj B; Department of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia.; Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Rollinson S; Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, UK.
Rossi G; Division of Neurology V and Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Rossmeier C; Technical University of Munich, School of Medicine, Department of Psychiatry and Psychotherapy, Munich, Germany.
Rowe JB; Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.; MRC Cognition and Brain Sciences Unit, Cambridge University, Cambridge, UK.
Rubino E; Neurology I, Department of Neuroscience, University of Torino, Torino, Italy.
Ruiz A; Research Center and Memory Clinic. Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Sanchez-Valle R; Alzheimer's disease and other cognitive disorders unit. Hospital Clínic of Barcelona, Barcelona, Spain.; Institud d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Sando SB; Department of Neurology, University Hospital of Trondheim, Trondheim, Norway.; Department of Neuromedicine and Movement science, Norwegian University of Science and Technology, Trondheim, Norway.
Santillo AF; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Saxon J; Manchester Centre for Clinical Neurosciences, Salford Royal NHS Trust, Manchester, UK.
Scarpini E; University of Milan, Dino Ferrari Center, Milan, Italy.; Fondazione IRCCS Ca' Granda, Ospedale Policlinico, Milan, Italy.
Serpente M; University of Milan, Dino Ferrari Center, Milan, Italy.; Fondazione IRCCS Ca' Granda, Ospedale Policlinico, Milan, Italy.
Smirne N; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Sorbi S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Suh E; Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Tagliavini F; Division of Neurology V and Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Thompson JC; Manchester Centre for Clinical Neurosciences, Salford Royal NHS Trust, Manchester, UK.; Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, UK.
Trojanowski JQ; Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Van Deerlin VM; Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Van der Zee J; Neurodegenerative Brain Diseases group, Center for Molecular Neurology, VIB, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Van Broeckhoven C; Neurodegenerative Brain Diseases group, Center for Molecular Neurology, VIB, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
van Rooij J; Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands.
Van Swieten JC; Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands.
Veronesi A; Immunohematology and Transfusional Medicine Service, Local Health Authority n.2 Marca Trevigiana, Treviso, Italy.
Vitale E; NeurOMICS laboratory, Institute of Biochemistry and Cell Biology (IBBC), CNR Napoli, Napoli, Italy.
Waldö ML; Division of Clinical Sciences Helsingborg, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Woodward C; Neurogenetics Laboratory, National Hospital for Neurology and Neurosurgery, London, UK.
Yokoyama J; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Escott-Price V; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK and Dementia Research Institute, Cardiff University, UK.
Polke JM; Neurogenetics Laboratory, National Hospital for Neurology and Neurosurgery, London, UK.
Ferrari R; University College London, Institute of Neurology, London, UK .
Pokaż więcej
Corporate Authors :
International FTD-Genetics Consortium (IFGC)
Źródło :
Neurology [Neurology] 2020 Sep 17. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Anterior temporal lobe is necessary for efficient lateralised processing of spoken word identity.
Autorzy :
Cope TE; Department of Clinical Neurosciences, University of Cambridge, UK; MRC Cognition and Brain Sciences Unit, University of Cambridge, UK. Electronic address: .
Shtyrov Y; MRC Cognition and Brain Sciences Unit, University of Cambridge, UK; Center of Functionally Integrative Neuroscience, Aarhus University, Denmark; Institute for Cognitive Neuroscience, NRU Higher School of Economics, Moscow, Russia.
MacGregor LJ; MRC Cognition and Brain Sciences Unit, University of Cambridge, UK.
Holland R; MRC Cognition and Brain Sciences Unit, University of Cambridge, UK; Division of Language and Communication Science, City University London, UK.
Pulvermüller F; MRC Cognition and Brain Sciences Unit, University of Cambridge, UK; Brain Language Laboratory, Department of Philosophy and Humanities, WE4, Freie Universität Berlin, Germany.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, UK; MRC Cognition and Brain Sciences Unit, University of Cambridge, UK.
Patterson K; Department of Clinical Neurosciences, University of Cambridge, UK; MRC Cognition and Brain Sciences Unit, University of Cambridge, UK.
Pokaż więcej
Źródło :
Cortex; a journal devoted to the study of the nervous system and behavior [Cortex] 2020 May; Vol. 126, pp. 107-118. Date of Electronic Publication: 2020 Jan 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum.
Autorzy :
Bevan-Jones WR; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Cope TE; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Jones PS; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Kaalund SS; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Passamonti L; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Istituto di Bioimmagini e Fisiologia Molecolare (IBFM), Consiglio Nazionale delle Ricerche (CNR), via Fratelli Cervi, Milano, Italy.
Allinson K; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridge, UK.
Green O; Istituto di Bioimmagini e Fisiologia Molecolare (IBFM), Consiglio Nazionale delle Ricerche (CNR), via Fratelli Cervi, Milano, Italy.
Hong YT; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Fryer TD; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Arnold R; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Coles JP; Division of Anaesthesia, University of Cambridge, UK.
Aigbirhio FI; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Larner AJ; Department of Neurology, The Walton Centre, Liverpool, UK.
Patterson K; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
O'Brien JT; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Rowe JB; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2020 Mar 01; Vol. 143 (3), pp. 1010-1026.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Protein Aggregates*
Frontotemporal Dementia/*metabolism
Inflammation/*metabolism
Aged ; Carbolines/metabolism ; Carbon Radioisotopes/metabolism ; Case-Control Studies ; DNA-Binding Proteins/metabolism ; Female ; Frontotemporal Dementia/complications ; Humans ; Inflammation/complications ; Isoquinolines/metabolism ; Male ; Microglia/metabolism ; Middle Aged ; Positron-Emission Tomography ; Protein Binding ; Tauopathies/metabolism
Czasopismo naukowe
Tytuł :
GABA-ergic Dynamics in Human Frontotemporal Networks Confirmed by Pharmaco-Magnetoencephalography.
Autorzy :
Adams NE; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom.
Hughes LE; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge CB2 7EF, United Kingdom, and.
Phillips HN; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge CB2 7EF, United Kingdom, and.
Shaw AD; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom.; Cardiff University Brain Research Imaging Centre, Cardiff University, Cardiff CF24 4HQ, United Kingdom.
Murley AG; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom.
Nesbitt D; Medical Research Council Cognition and Brain Sciences Unit, Cambridge CB2 7EF, United Kingdom, and.
Cope TE; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom.
Bevan-Jones WR; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom.
Passamonti L; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom.
Rowe JB; Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, United Kingdom, .; Medical Research Council Cognition and Brain Sciences Unit, Cambridge CB2 7EF, United Kingdom, and.
Pokaż więcej
Źródło :
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2020 Feb 19; Vol. 40 (8), pp. 1640-1649. Date of Electronic Publication: 2020 Jan 08.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Models, Neurological*
Auditory Cortex/*diagnostic imaging
Frontal Lobe/*diagnostic imaging
Nerve Net/*diagnostic imaging
Neurons/*physiology
Aged ; Auditory Cortex/drug effects ; Cross-Over Studies ; Double-Blind Method ; Female ; Frontal Lobe/drug effects ; GABA Uptake Inhibitors/pharmacology ; Humans ; Magnetoencephalography/methods ; Male ; Middle Aged ; Nerve Net/drug effects ; Neurons/drug effects ; Tiagabine/pharmacology
Czasopismo naukowe
Tytuł :
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.
Autorzy :
Moore KM; Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK.
Nicholas J; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Grossman M; Department of Neurology, Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
McMillan CT; Department of Neurology, Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
Irwin DJ; Department of Neurology, Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
Massimo L; Department of Neurology, Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
Van Deerlin VM; Department of Neurology, Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
Warren JD; Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK.
Fox NC; Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK.
Rossor MN; Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK.
Mead S; Institute of Prion Diseases, University College London, London, UK.
Bocchetta M; Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK.
Boeve BF; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Knopman DS; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Forsberg LK; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Wszolek ZK; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
van Swieten JC; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Jiskoot LC; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Meeter LH; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Dopper EG; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Papma JM; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Snowden JS; Cerebral Function Unit, Salford Royal NHS Foundation Trust and Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.
Saxon J; Cerebral Function Unit, Salford Royal NHS Foundation Trust and Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.
Jones M; Cerebral Function Unit, Salford Royal NHS Foundation Trust and Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.
Pickering-Brown S; Cerebral Function Unit, Salford Royal NHS Foundation Trust and Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.
Le Ber I; Institut du Cerveau et de la Moelle épinière & Centre de Référence des Démences Rares ou précoces, Institut de la Mémoire et de la Maladie d'Alzheimer, Assistance Publique-Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, Paris, France.
Camuzat A; Institut du Cerveau et de la Moelle épinière & Centre de Référence des Démences Rares ou précoces, Institut de la Mémoire et de la Maladie d'Alzheimer, Assistance Publique-Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, Paris, France.
Brice A; Institut du Cerveau et de la Moelle épinière & Centre de Référence des Démences Rares ou précoces, Institut de la Mémoire et de la Maladie d'Alzheimer, Assistance Publique-Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, Paris, France.
Caroppo P; Institut du Cerveau et de la Moelle épinière & Centre de Référence des Démences Rares ou précoces, Institut de la Mémoire et de la Maladie d'Alzheimer, Assistance Publique-Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, Paris, France.
Ghidoni R; Molecular Markers Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Pievani M; Alzheimer's Neuroimaging & Epidemiology Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Benussi L; Molecular Markers Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Binetti G; Molecular Markers Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Dickerson BC; Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Lucente D; Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Krivensky S; Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Graff C; Center for Alzheimer Research, Division of Neurogenetics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Öijerstedt L; Center for Alzheimer Research, Division of Neurogenetics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Fallström M; Center for Alzheimer Research, Division of Neurogenetics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Thonberg H; Center for Alzheimer Research, Division of Neurogenetics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Ghoshal N; Department of Neurology, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, MO, USA.
Morris JC; Department of Neurology, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, MO, USA.
Borroni B; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Benussi A; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Padovani A; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Galimberti D; Department of Biomedical, Surgical and Dental Sciences, Centro Dino Ferrari, University of Milan, Milan, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Scarpini E; Department of Pathophysiology and Transplantation, Centro Dino Ferrari, University of Milan, Milan, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Fumagalli GG; Department of Pathophysiology and Transplantation, Centro Dino Ferrari, University of Milan, Milan, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy; Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Mackenzie IR; Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Hsiung GR; Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Sengdy P; Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Boxer AL; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, USA.
Rosen H; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, USA.
Taylor JB; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, USA.
Synofzik M; Department of Neurodegenerative Diseases, Center for Neurology and Hertie-Institute for Clinical Brain Research, Tübingen, Germany; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Wilke C; Department of Neurodegenerative Diseases, Center for Neurology and Hertie-Institute for Clinical Brain Research, Tübingen, Germany; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Sulzer P; Department of Neurodegenerative Diseases, Center for Neurology and Hertie-Institute for Clinical Brain Research, Tübingen, Germany; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Hodges JR; Brain and Mind Centre & Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Halliday G; Brain and Mind Centre & Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Kwok J; Brain and Mind Centre & Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Lladó A; Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Borrego-Ecija S; Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Santana I; Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Neurology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Almeida MR; Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Tábuas-Pereira M; Neurology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia Universitary Hospital, San Sebastian, Spain; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Spain; Center for Networked Biomedical Research on Neurodegenerative Disease, Carlos III Health Institute, Madrid, Spain.
Barandiaran M; Cognitive Disorders Unit, Department of Neurology, Donostia Universitary Hospital, San Sebastian, Spain; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Spain; Center for Networked Biomedical Research on Neurodegenerative Disease, Carlos III Health Institute, Madrid, Spain.
Indakoetxea B; Cognitive Disorders Unit, Department of Neurology, Donostia Universitary Hospital, San Sebastian, Spain; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Spain; Center for Networked Biomedical Research on Neurodegenerative Disease, Carlos III Health Institute, Madrid, Spain.
Levin J; Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany.
Danek A; Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Cope TE; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
Anderl-Straub S; Department of Neurology, University of Ulm, Ulm, Germany.
de Mendonça A; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Maruta C; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Masellis M; Division of Neurology, Department of Medicine, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Black SE; Division of Neurology, Department of Medicine, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Couratier P; Centre de Compétence Démences Rares, Centre Hospitalier et Universitaire Limoges, Limoges, France.
Lautrette G; Centre de Compétence Démences Rares, Centre Hospitalier et Universitaire Limoges, Limoges, France.
Huey ED; Departments of Psychiatry and Neurology, Columbia University, New York, NY, USA.
Sorbi S; Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Don Carlo Gnocchi, Florence, Italy.
Nacmias B; Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Laforce R Jr; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Hôpital de l'Enfant-Jésus, and Faculté de Médecine, Université Laval, Québec, QC, Canada.
Tremblay ML; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Hôpital de l'Enfant-Jésus, and Faculté de Médecine, Université Laval, Québec, QC, Canada.
Vandenberghe R; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
Damme PV; Department of Neurology, University Hospitals Leuven, Leuven, Belgium; Center for Brain & Disease Research, VIB, Leuven, Belgium.
Rogalski EJ; Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University, Chicago, IL, USA.
Weintraub S; Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University, Chicago, IL, USA.
Gerhard A; Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK; Departments of Nuclear Medicine and Geriatric Medicine, University Hospital Essen, Essen, Germany.
Onyike CU; Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ducharme S; Montreal Neurological Institute, McConnell Brain Imaging Centre, McGill University Health Centre, McGill University, Montreal, QC, Canada.
Papageorgiou SG; Cognitive Disorders/Dementia Unit, 2nd Department of Neurology, National and Kapodistrian University of Athens, Attikon University General Hospital, Athens, Greece.
Ng ASL; Department of Neurology, National Neuroscience Institute, Singapore, Singapore.
Brodtmann A; Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada.
Guerreiro R; Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA.
Bras J; Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA.
Rohrer JD; Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK. Electronic address: .
Pokaż więcej
Corporate Authors :
FTD Prevention Initiative
Źródło :
The Lancet. Neurology [Lancet Neurol] 2020 Feb; Vol. 19 (2), pp. 145-156. Date of Electronic Publication: 2019 Dec 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Age of Onset*
Frontotemporal Dementia/*genetics
Frontotemporal Dementia/*mortality
Adult ; Aged ; Aged, 80 and over ; C9orf72 Protein/genetics ; C9orf72 Protein/metabolism ; Cohort Studies ; Disease Progression ; Family ; Female ; Humans ; Male ; Middle Aged ; Mutation ; Phenotype ; Progranulins/genetics ; Progranulins/metabolism ; Retrospective Studies ; tau Proteins/genetics ; tau Proteins/metabolism
Czasopismo naukowe
Tytuł :
Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer's Disease and Frontotemporal Dementia.
Autorzy :
Nicastro N; Department of Psychiatry, University of Cambridge, UK.; Department of Clinical Neurosciences, Geneva University Hospitals, Switzerland.
Malpetti M; Department of Clinical Neurosciences, University of Cambridge, UK.
Cope TE; Department of Clinical Neurosciences, University of Cambridge, UK.
Bevan-Jones WR; Department of Clinical Neurosciences, University of Cambridge, UK.
Mak E; Department of Psychiatry, University of Cambridge, UK.
Passamonti L; Department of Clinical Neurosciences, University of Cambridge, UK.; Consiglio Nazionale delle Ricerche (CNR), Istituto di Bioimmagini e Fisiologia Molecolare (IBFM), Milano, Italy.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
O'Brien JT; Department of Psychiatry, University of Cambridge, UK.
Pokaż więcej
Źródło :
Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2020; Vol. 76 (1), pp. 331-340.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier.
Autorzy :
Bevan-Jones WR; Department of Psychiatry University of Cambridge Cambridge United Kingdom.
Cope TE; Department of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.
Jones PS; Department of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.
Passamonti L; Department of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.
Hong YT; Wolfson Brain Imaging Centre University of Cambridge Cambridge United Kingdom.
Fryer T; Wolfson Brain Imaging Centre University of Cambridge Cambridge United Kingdom.
Arnold R; Department of Psychiatry University of Cambridge Cambridge United Kingdom.
Coles JP; Division of Anaesthesia University of Cambridge Cambridge United Kingdom.
Aigbirhio FI; Wolfson Brain Imaging Centre University of Cambridge Cambridge United Kingdom.
O'Brien JT; Department of Psychiatry University of Cambridge Cambridge United Kingdom.
Rowe JB; Department of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit Cambridge United Kingdom.
Pokaż więcej
Źródło :
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2019 Jan 02; Vol. 6 (2), pp. 373-378. Date of Electronic Publication: 2019 Jan 02 (Print Publication: 2019).
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Frontotemporal Dementia/*genetics
Mutation/*genetics
tau Proteins/*genetics
tau Proteins/*metabolism
Atrophy/genetics ; Atrophy/metabolism ; Brain/metabolism ; Female ; Heterozygote ; Humans ; Longitudinal Studies ; Magnetic Resonance Imaging/methods ; Middle Aged ; Positron-Emission Tomography/methods
Czasopismo naukowe
Tytuł :
[ F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia.
Autorzy :
Bevan-Jones WR; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Cope TE; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Jones PS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Passamonti L; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Hong YT; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Fryer TD; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Arnold R; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Allinson KSJ; Department of Pathology, Addenbrooke's Hospital, Cambridge, UK.
Coles JP; Division of Anaesthesia, University of Cambridge, Cambridge, UK.
Aigbirhio FI; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Patterson K; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Cognition and Brain Sciences Unit, Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
O'Brien JT; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Cognition and Brain Sciences Unit, Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
Pokaż więcej
Źródło :
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2018 Oct; Vol. 89 (10), pp. 1032-1037. Date of Electronic Publication: 2017 Sep 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Aphasia, Primary Progressive/*diagnostic imaging
DNA-Binding Proteins/*metabolism
Aged ; Aphasia, Primary Progressive/metabolism ; Brain/metabolism ; Female ; Humans ; Male ; Middle Aged ; Positron-Emission Tomography
Czasopismo naukowe
Tytuł :
[ F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion.
Autorzy :
Bevan-Jones RW; Department of Psychiatry University of Cambridge Cambridge United Kingdom.
Cope TE; Department of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.
Jones SP; Department of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.
Passamonti L; Department of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.
Hong YT; Wolfson Brain Imaging Centre University of Cambridge Cambridge United Kingdom.
Fryer T; Wolfson Brain Imaging Centre University of Cambridge Cambridge United Kingdom.
Arnold R; Department of Psychiatry University of Cambridge Cambridge United Kingdom.
Coles JP; Division of Anaesthesia University of Cambridge Cambridge United Kingdom.
Aigbirhio FA; Wolfson Brain Imaging Centre University of Cambridge Cambridge United Kingdom.
Patterson K; Department of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit Cambridge United Kingdom.
O'Brien JT; Department of Psychiatry University of Cambridge Cambridge United Kingdom.
Rowe JB; Department of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit Cambridge United Kingdom.
Pokaż więcej
Źródło :
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2018 Sep 14; Vol. 5 (10), pp. 1292-1296. Date of Electronic Publication: 2018 Sep 14 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype.
Autorzy :
Sami S; Department of Clinical Neurosciences, University of Cambridge, UK.
Williams N; Neuroscience Center, University of Helsinki, Finland.
Hughes LE; Department of Clinical Neurosciences, University of Cambridge, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
Cope TE; Department of Clinical Neurosciences, University of Cambridge, UK.
Rittman T; Department of Clinical Neurosciences, University of Cambridge, UK.
Coyle-Gilchrist ITS; Department of Clinical Neurosciences, University of Cambridge, UK.
Henson RN; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2018 Aug 01; Vol. 141 (8), pp. 2500-2510.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Alzheimer Disease/*pathology
Frontotemporal Lobar Degeneration/*pathology
Aged ; Alzheimer Disease/diagnosis ; Biomarkers ; Brain/pathology ; Connectome ; Diagnostic Techniques, Neurological ; Female ; Frontotemporal Dementia/pathology ; Frontotemporal Lobar Degeneration/diagnosis ; Humans ; Magnetic Resonance Imaging/methods ; Magnetoencephalography/methods ; Male ; Middle Aged ; Nerve Net/pathology ; Neurodegenerative Diseases/pathology ; Neurophysiology/methods ; Phenotype ; Temporal Lobe/pathology
Czasopismo naukowe
Tytuł :
Monitoring the past and choosing the future: the prefrontal cortical influences on voluntary action.
Autorzy :
Phillips HN; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK. .; Medical Research Council, Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK. .
Cope TE; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
Hughes LE; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Medical Research Council, Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK.
Zhang J; School of Psychology, University of Cardiff, Cardiff, CF2 2AT, UK.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Medical Research Council, Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK.; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2018 May 08; Vol. 8 (1), pp. 7247. Date of Electronic Publication: 2018 May 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Choice Behavior/*physiology
Prefrontal Cortex/*physiology
Adolescent ; Adult ; Decision Making/physiology ; Female ; Humans ; Magnetic Resonance Imaging ; Magnetoencephalography ; Male ; Prefrontal Cortex/diagnostic imaging ; Reaction Time/physiology ; Young Adult
Czasopismo naukowe
Tytuł :
Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
Autorzy :
Cope TE; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Rittman T; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Borchert RJ; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Jones PS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Vatansever D; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Department of Psychology, University of York, York, UK.; Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK.; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Allinson K; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Passamonti L; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Vazquez Rodriguez P; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Bevan-Jones WR; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Department of Psychiatry, University of Cambridge, Cambridge, UK.
O'Brien JT; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2018 Feb 01; Vol. 141 (2), pp. 550-567.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Alzheimer Disease/*diagnostic imaging
Alzheimer Disease/*metabolism
Connectome/*methods
Supranuclear Palsy, Progressive/*diagnostic imaging
Supranuclear Palsy, Progressive/*metabolism
tau Proteins/*metabolism
Aged ; Aged, 80 and over ; Alzheimer Disease/pathology ; Aniline Compounds/pharmacokinetics ; Brain Mapping ; Carbolines/pharmacokinetics ; Female ; Humans ; Image Processing, Computer-Assisted ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neural Pathways/diagnostic imaging ; Oxygen/blood ; Positron-Emission Tomography ; Rest ; Supranuclear Palsy, Progressive/pathology ; Thiazoles/pharmacokinetics
Czasopismo naukowe
Tytuł :
Evidence for causal top-down frontal contributions to predictive processes in speech perception.
Autorzy :
Cope TE; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK. .
Sohoglu E; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Sedley W; Institute of Neuroscience, Newcastle University, Newcastle, NE1 7RU, UK.
Patterson K; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Jones PS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
Wiggins J; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
Dawson C; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
Grube M; Institute of Neuroscience, Newcastle University, Newcastle, NE1 7RU, UK.
Carlyon RP; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Griffiths TD; Institute of Neuroscience, Newcastle University, Newcastle, NE1 7RU, UK.
Davis MH; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2017 Dec 18; Vol. 8 (1), pp. 2154. Date of Electronic Publication: 2017 Dec 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Frontal Lobe/*physiopathology
Primary Progressive Nonfluent Aphasia/*physiopathology
Speech Perception/*physiology
Temporal Lobe/*physiopathology
Acoustic Stimulation ; Aged ; Brain Mapping ; Electroencephalography ; Female ; Humans ; Magnetoencephalography ; Male ; Nerve Net/physiopathology ; Speech/physiology
Czasopismo naukowe
Tytuł :
Artificial grammar learning in vascular and progressive non-fluent aphasias.
Autorzy :
Cope TE; Department of Clinical Neurosciences, University of Cambridge, UK; Institute of Neuroscience, Newcastle University, UK. Electronic address: .
Wilson B; Institute of Neuroscience, Newcastle University, UK.
Robson H; School of Psychology and Clinical Language Sciences, University of Reading, UK.
Drinkall R; School of Psychology and Clinical Language Sciences, University of Reading, UK.
Dean L; Institute of Neuroscience, Newcastle University, UK.
Grube M; Institute of Neuroscience, Newcastle University, UK.
Jones PS; Department of Clinical Neurosciences, University of Cambridge, UK.
Patterson K; Department of Clinical Neurosciences, University of Cambridge, UK; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
Griffiths TD; Institute of Neuroscience, Newcastle University, UK.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, UK; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
Petkov CI; Institute of Neuroscience, Newcastle University, UK.
Pokaż więcej
Źródło :
Neuropsychologia [Neuropsychologia] 2017 Sep; Vol. 104, pp. 201-213. Date of Electronic Publication: 2017 Aug 24.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Mapping*
Linguistics*
Semantics*
Aphasia, Broca/*complications
Learning/*physiology
Primary Progressive Nonfluent Aphasia/*complications
Acoustic Stimulation ; Aged ; Aged, 80 and over ; Aphasia, Broca/etiology ; Female ; Humans ; Machine Learning ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neuropsychological Tests ; Primary Progressive Nonfluent Aphasia/diagnostic imaging ; Primary Progressive Nonfluent Aphasia/etiology ; Statistics as Topic ; Stroke/complications ; Vocabulary
Czasopismo naukowe
Tytuł :
18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
Autorzy :
Passamonti L; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Istituto di Bioimmagini e Fisiologia Molecolare, Consiglio Nazionale delle Ricerche, Milano, Italy.
Vázquez Rodríguez P; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Hong YT; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Allinson KS; Department of Histopathology, Cambridge University Hospital, Cambridge, UK.
Williamson D; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Borchert RJ; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Sami S; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Cope TE; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Bevan-Jones WR; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Jones PS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Arnold R; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Surendranathan A; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Mak E; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Su L; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Fryer TD; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Aigbirhio FI; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
O'Brien JT; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2017 Mar 01; Vol. 140 (3), pp. 781-791.
Typ publikacji :
Journal Article
MeSH Terms :
Alzheimer Disease/*diagnostic imaging
Brain/*diagnostic imaging
Carbolines/*pharmacokinetics
Supranuclear Palsy, Progressive/*diagnostic imaging
Aged ; Aged, 80 and over ; Alzheimer Disease/complications ; Autopsy ; Autoradiography ; Brain/drug effects ; Brain/metabolism ; Case-Control Studies ; Cognition Disorders/diagnostic imaging ; Cognition Disorders/etiology ; Female ; Fluorodeoxyglucose F18/pharmacokinetics ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neuropsychological Tests ; Positron-Emission Tomography/methods ; Protein Binding/drug effects ; Psychiatric Status Rating Scales ; Supranuclear Palsy, Progressive/complications ; tau Proteins/metabolism
Czasopismo naukowe
Tytuł :
The Brain Basis for Misophonia.
Autorzy :
Kumar S; Institute of Neuroscience, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Wellcome Trust Centre for Neuroimaging, 12 Queen Square, London WC1N 3BG, UK. Electronic address: .
Tansley-Hancock O; Institute of Neuroscience, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Sedley W; Institute of Neuroscience, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Winston JS; Wellcome Trust Centre for Neuroimaging, 12 Queen Square, London WC1N 3BG, UK; Institute of Cognitive Neuroscience, 17 Queen Square, London WC1N 3AR, UK.
Callaghan MF; Wellcome Trust Centre for Neuroimaging, 12 Queen Square, London WC1N 3BG, UK.
Allen M; Wellcome Trust Centre for Neuroimaging, 12 Queen Square, London WC1N 3BG, UK.
Cope TE; Institute of Neuroscience, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK.
Gander PE; Human Brain Research Laboratory, Department of Neurosurgery, The University of Iowa, Iowa City, IA 52242, USA.
Bamiou DE; UCL Ear Institute, 332 Grays Inn Road, London WC1X 8EE, UK.
Griffiths TD; Institute of Neuroscience, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Wellcome Trust Centre for Neuroimaging, 12 Queen Square, London WC1N 3BG, UK.
Pokaż więcej
Źródło :
Current biology : CB [Curr Biol] 2017 Feb 20; Vol. 27 (4), pp. 527-533. Date of Electronic Publication: 2017 Feb 02.
Typ publikacji :
Journal Article
MeSH Terms :
Anger/*physiology
Anxiety Disorders/*physiopathology
Brain/*physiopathology
Cerebral Cortex/*physiology
Sound/*adverse effects
Adult ; Anxiety Disorders/diagnostic imaging ; Brain/diagnostic imaging ; Cerebral Cortex/diagnostic imaging ; Emotions/physiology ; Female ; Galvanic Skin Response ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
[ F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation.
Autorzy :
Bevan Jones WR; Department of Psychiatry University of Cambridge Cambridge UK.
Cope TE; Department of Clinical Neurosciences University of Cambridge Cambridge UK.
Passamonti L; Department of Psychiatry University of Cambridge Cambridge UK.
Fryer TD; Department of Clinical Neurosciences University of Cambridge Cambridge UK.
Hong YT; Department of Clinical Neurosciences University of Cambridge Cambridge UK.
Aigbirhio F; Wolfson Brain Imaging Centre University of Cambridge Cambridge UK.
Kril JJ; Discipline of Pathology University of Sydney Sydney Australia.
Forrest SL; Discipline of Pathology University of Sydney Sydney Australia.
Allinson K; Department of Neuropathology Addenbrooke's Hospital Cambridge UK.
Coles JP; Wolfson Brain Imaging Centre University of Cambridge Cambridge UK; Division of Anaesthesia, University of Cambridge Cambridge UK.
Simon Jones P; Department of Clinical Neurosciences University of Cambridge Cambridge UK.
Spillantini MG; Department of Clinical Neurosciences University of Cambridge Cambridge UK.
Hodges JR; University of New South Wales Sydney Australia.
O'Brien JT; Department of Psychiatry University of Cambridge Cambridge UK.
Rowe JB; Department of Clinical Neurosciences University of Cambridge Cambridge UK; Medical Research Council Cognition and Brain Sciences Unit Cambridge UK.
Pokaż więcej
Źródło :
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2016 Oct 18; Vol. 3 (12), pp. 940-947. Date of Electronic Publication: 2016 Oct 18 (Print Publication: 2016).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies